-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496

Benzinga·10/07/2026 13:54:04
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $435 to $496.